118.50
+0.50
+(0.42%)
At close: January 31 at 7:31:17 PM GMT+1
Key Executives
Key Executives Information Not Available
BioNTech SE
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
BioNTech SE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 4, 2024 at 1:30 PM UTC
BioNTech SE Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
B1MR34.SA BioMarin Pharmaceutical Inc.
186.90
0.00%
REGN34.SA Regeneron Pharmaceuticals, Inc.
65.74
-1.81%
49B.F BeiGene, Ltd.
16.80
+0.60%
BM8.MU Biomarin Pharmaceutical Inc
61.58
+0.95%
TECH Bio-Techne Corporation
73.55
+1.09%
HALO Halozyme Therapeutics, Inc.
56.64
+0.39%
GPCR Structure Therapeutics Inc.
29.97
-1.15%
GMAB.CO Genmab A/S
1,424.50
+1.03%
MDGL Madrigal Pharmaceuticals, Inc.
334.80
-1.03%
INO Inovio Pharmaceuticals, Inc.
2.0900
0.00%